253 related articles for article (PubMed ID: 35339897)
1. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction.
Wang S; Hu S; Luo X; Bao X; Li J; Liu M; Lv Y; Zhao C; Zeng M; Chen X; Unsworth A; Jones S; Johnson TW; White SJ; Jia H; Yu B
EBioMedicine; 2022 Apr; 78():103964. PubMed ID: 35339897
[TBL] [Abstract][Full Text] [Related]
2. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
[TBL] [Abstract][Full Text] [Related]
3. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
[TBL] [Abstract][Full Text] [Related]
4. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
[TBL] [Abstract][Full Text] [Related]
5. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
6. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
7. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
9. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
10. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
[TBL] [Abstract][Full Text] [Related]
11. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
[TBL] [Abstract][Full Text] [Related]
12. Natural history of clonal haematopoiesis seen in real-world haematology settings.
Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.
Cobo I; Tanaka TN; Chandra Mangalhara K; Lana A; Yeang C; Han C; Schlachetzki J; Challcombe J; Fixsen BR; Sakai M; Li RZ; Fields H; Mokry M; Tsai RG; Bejar R; Prange K; de Winther M; Shadel GS; Glass CK
Immunity; 2022 Aug; 55(8):1386-1401.e10. PubMed ID: 35931086
[TBL] [Abstract][Full Text] [Related]
14. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
[TBL] [Abstract][Full Text] [Related]
15. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
[TBL] [Abstract][Full Text] [Related]
16. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation.
Mas-Peiro S; Hoffmann J; Fichtlscherer S; Dorsheimer L; Rieger MA; Dimmeler S; Vasa-Nicotera M; Zeiher AM
Eur Heart J; 2020 Feb; 41(8):933-939. PubMed ID: 31504400
[TBL] [Abstract][Full Text] [Related]
17.
Maifrede S; Le BV; Nieborowska-Skorska M; Golovine K; Sullivan-Reed K; Dunuwille WMB; Nacson J; Hulse M; Keith K; Madzo J; Caruso LB; Gazze Z; Lian Z; Padella A; Chitrala KN; Bartholdy BA; Matlawska-Wasowska K; Di Marcantonio D; Simonetti G; Greiner G; Sykes SM; Valent P; Paietta EM; Tallman MS; Fernandez HF; Litzow MR; Minden MD; Huang J; Martinelli G; Vassiliou GS; Tempera I; Piwocka K; Johnson N; Challen GA; Skorski T
Cancer Res; 2021 Oct; 81(19):5089-5101. PubMed ID: 34215619
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
19. Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR.
Mas-Peiro S; Pergola G; Berkowitsch A; Meggendorfer M; Rieger MA; Vasa-Nicotera M; Dimmeler S; Zeiher AM
Clin Res Cardiol; 2023 May; 112(5):585-593. PubMed ID: 36680616
[TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
